Bringing the fundamentals into focus…
Back to Contineum Therapeutics, Inc.
How Contineum Therapeutics, Inc. stacks up
CTNM · against 387 other Healthcare companies of similar size
Profitability
21/ 100
Below the middle of the pack.
Ranked #286 of 388 · scores higher than 25% of peers
Bars: peers in each 10-point band of the profitability score53 peers with a profitability score of 20–29, including CTNM · Click a bar to see the companies
Why profitability scores 21?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 82% of peers. Return on assets: -23.0% vs peer median 1.7%
- a lower return on invested capital: weaker than 80% of peers. Return on invested capital: -23.3% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = CTNM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CTNM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 357 reported | -23.3% | 0.5% | 26% | 33% | |
| Operating marginHigher is better · 359 reported | Not reported | 2.9% | — | — | 33% |
| Return on assetsHigher is better · 386 reported | -23.0% | -0.2% | 24% | 33% | |
| Return on equityHigher is better · 365 reported | -28.0% | -1.3% | 29% | Context only | |
| Gross marginHigher is better · 406 reported | 0.0% | 37.1% | 5% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CTNM| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 283 | 239M USD | 22 | 38 | |
| 283 | 394M USD | 22 | 37 | |
| 286 | 1.6B HKD (≈$209M) | 21 | 54 | |
| 286 | 560M USD | 21 | 42 | |
| 286 | 365M USD | 21 | 41 | |
| 286 | 486M USD | 21 | 16 | |
| 286 | 375M USD | 21 | 46 | |
| 286 | 285M USD | 21 | 38 | |
| 292 | 222M USD | 20 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score